查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
輻射劑量管理市場 - 全球和區域分析：依產品、形式、部署類型、應用、最終用戶和國家 - 分析和預測（2025-2035年）
市場調查報告書
商品編碼
1694064

輻射劑量管理市場 - 全球和區域分析：依產品、形式、部署類型、應用、最終用戶和國家 - 分析和預測（2025-2035年）

Radiation Dose Management Market - A Global and Regional Analysis: Focus on Product, Modality, Mode of Deployment, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 | 商品交期: 1-5個工作天內

價格
簡介目錄

預計到2035年全球輻射劑量管理市場規模將以 10.45%的年複合成長率成長。

全球輻射劑量管理市場的成長預計將受到需要診斷干預的慢性病患病率上升、對介入放射學（IR）的日益關注以及對患者安全和過度暴露於電離輻射的不良生物學影響的認知不斷提高的推動。

輻射劑量管理市場處於新興市場階段。雲端劑量管理解決方案的開發和對兒科手術輻射劑量管理的日益關注是全球輻射劑量管理市場的一些主要機會。此外，市場上的一些主要持續趨勢包括利用減少輻射劑量的技術開發顯像模式的不斷增加、市場獨家夥伴關係、戰略商業聯盟以及市場參與企業之間的各種合作關係。

估計2024年全球輻射劑量管理市場（依形式）將由 CT 掃描儀領域主導，並且預計這一趨勢將持續到2025-2035年預測期年終。依產品分類，Radimetrics Enterprise Platform 佔據絕對領先地位，其次是 DoseWatch。在部署類型方面，基於 Web 的區隔占主導地位。從終端用戶來看，醫院佔了絕對的佔有率。

放射裝置數量和掃描次數的增加增加了輻射暴露的風險，增加了對劑量管理解決方案的需求。心血管疾病發生率的上升和導管室職業傷害的增加引發了人們對輻射暴露影響的擔憂。人們對介入放射學（IR）的日益關注預計將增加對紅外線成像系統的需求並增加輻射暴露的風險。人們對輻射過度暴露的擔憂日益增加，導致劑量管理解決方案的採用率不斷提高。預計對輻射劑量管理的認知和舉措的增強將推動劑量管理軟體的採用。各國劑量最佳化和基準測試的進步將推動醫療機構採用劑量管理軟體。

產品類型有助於了解醫院和診斷中心可用的各種類型的輻射劑量控制軟體。此外，可根據支援的模式（CT 掃描儀、X 光、CR、DR、乳房X光攝影X 光照相系統、介入性血管造影系統/血管造影 CT、透視系統、PET 掃描儀、SPECT、混合成像）、血管造影術模式（雲端基礎、基於網路、本地）和可部署的最終用戶（醫院、診斷中心等）深入了解各種輻射劑量管理軟體。

全球輻射劑量管理市場見證主要企業之間的夥伴關係、聯盟、業務擴張和新產品的發布。夥伴關係最為普遍，佔全球輻射劑量管理市場整體發展的近 70.00%。

本報告研究了全球輻射劑量管理市場，並概述了市場狀況以及依產品、方式、實施類型、應用、最終用戶、國家分類的趨勢，和參與市場的公司概況。

目錄

執行摘要

第1章 市場概況

  • 概述
  • 主要趨勢
  • 機會評估
  • 專利分析
  • 比較分析
  • 市場差距分析
  • 定價分析
  • 競爭格局與產品需求的變化

第2章 市場動態

  • 概述
    • 影響分析
  • 市場促進因素
  • 市場限制
  • 市場機會

第3章 全球輻射劑量管理市場：競爭格局

  • 概述
  • 企業策略
  • 商務策略
    • 產品發布和核准
    • 出版品
    • 許可和協議
    • 其他活動
  • 市場佔有率分析

第4章 全球輻射劑量管理市場（依形式），金額（百萬美元），2023年至2035年

  • 概述
  • CT 掃描儀
  • X 光、CR、DR
  • 乳房攝影系統
  • 介入性血管造影術系統/血管CT
  • 透視系統
  • PET 掃描器和 SPECT
  • 混合成像

第5章 全球輻射劑量管理市場（依產品），金額（百萬美元），2023年至2035年

  • 概述
  • Radimetrics Enterprise Platform
  • DoseWatch and DoseWatch Explore
  • teamplay Dose
  • Nexo[DOSE]
  • tqm/Dose and DoseMonitor
  • Radiation Dose Monitor
  • Imalogix Platform
  • Syncro-Dose
  • NovaDose
  • DoseWise Portal
  • SafeCT
  • MyXrayDose
  • DoseM
  • Dose Tracking System
  • DoseTrack

第6章 全球輻射劑量管理市場（依部署方式)，金額（百萬美元），2023-2035年

  • 概述
  • 網路
  • 本地
  • 雲端

第7章 全球輻射劑量管理市場（依應用)，金額（百萬美元），2023年至2035年

  • 概述
  • 腫瘤學
  • 心臟病學
  • 整形外科
  • 其他

第8章 全球輻射劑量管理市場（依最終用戶），金額（百萬美元），2023-2035年

  • 概述
  • 醫院
  • 診斷中心
  • 其他

第9章 全球輻射劑量管理市場（依地區)，金額（百萬美元），2023年至2035年

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 荷蘭
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲和紐西蘭
    • 韓國
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東
    • 中東
    • 非洲

第10章 公司簡介

  • Agfa-Gevaert Group
  • Bracco
  • Bayer AG
  • Canon Inc.
  • FUJIFILM Holdings Corporation
  • Guerbet
  • General Electric Company
  • Imalogix
  • Infinitt Healthcare Co., Ltd.
  • LANDAUER
  • Medsquare
  • Medic Vision Imaging Solutions Ltd.
  • MyXrayDose Ltd.
  • Novarad Corporation
  • PACSHealth, LLC
  • Qaelum NV
  • Sectra AB
  • SST Group Inc.
  • Siemens Healthineers AG
  • Virtual Phantoms Inc.
簡介目錄
Product Code: BHD0692SE

Global Radiation Dose Management Market: Industry Overview

The global radiation dose management market is expected to grow at a CAGR of 10.45% by 2035. The growth in the global radiation dose management market is expected to be driven by the rising prevalence of chronic disorders requiring diagnostic intervention, the growing focus on interventional radiology (IR), and the growing awareness surrounding patient safety and the harmful and biological effects of overexposure to ionizing radiation.

Market Lifecycle Stage

The radiation dose management market is in the developing phase. The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players.

Market Segmentation:

Segmentation 1: by Modality

  • CT Scanners
  • X-Ray, CR, and DR
  • Mammography Systems
  • Interventional Angiography Systems/Angio CT
  • Fluoroscopy Systems
  • PET Scanners and SPECT
  • Hybrid Imaging

The global radiation dose management market (by modality) was dominated by the CT scanners segment in 2024, and the trend is expected to continue till the end of the forecast period 2025-2035.

Segmentation 2: by Product

  • Radimetrics Enterprise Platform
  • DoseWatch and DoseWatch Explore
  • teamplay Dose
  • NEXO [DOSE]
  • tqm/Dose and DoseMonitor
  • Radiation Dose Monitor
  • Imalogix Platform
  • Syncro-Dose
  • NovaDose
  • DoseWise Portal
  • SafeCT
  • MyXrayDose
  • DoseM
  • Dose Tracking System
  • DoseTrack

The global radiation dose management market (by product) is dominated by the Radimetrics Enterprise Platform, followed by DoseWatch.

Segmentation 3: by Mode of Deployment

  • Web-Based
  • On-Premise
  • Cloud-Based

The global radiation dose management market (by mode of deployment) is dominated by the web-based segment.

Segmentation 4: by Application

  • Oncology
  • Cardiology
  • Orthopedic
  • Other Application

The global radiation dose management market (by application) is dominated by the oncology segment.

Segmentation 5: by End User

  • Hospitals
  • Diagnostic Centers
  • Others

The global radiation dose management market (by end user) is dominated by the hospitals segment.

Segmentation 6: by Region

  • North America- U.S. and Canada
  • Europe- Germany, France, U.K., Italy, Spain, Netherlands, and Rest-of-Europe
  • Asia-Pacific- Japan, China, India, Australia and New Zealand, South Korea, and Rest-of-Asia-Pacific
  • Latin America- Brazil, Mexico, and Rest-of-Latin America
  • Middle East and Africa

Recent Developments in the Global Radiation Dose Management Market

  • In December 2020, Bayer AG launched Radimetrics v3.0, the latest evolution of its enterprise dose management utility.
  • In December 2020, FUJIFILM Holdings Corporation launched the unique SYNAPSE Dose 2.0 to provide a comprehensive system for managing patient radiation exposure across several imaging modalities.
  • In January 2020, Agfa HealthCare collaborated with Maasstad Hospital in the Netherlands to support advancements in the consistency and optimization of radiation doses.
  • In April 2019, Qaelum NV signed an agreement with TOYO Corporation to distribute its dose monitoring solution, DOSE, in Japan.
  • In January 2019, SST Group, Inc. partnered with Intermountain Healthcare to implement a software platform for the Radiation Dose Monitor (RDM). The software platform permits medical professionals to manage, examine, and optimize the dose delivered to a patient during interventional procedures, medical imaging examinations, and image-guided surgery.
  • In August 2018, Imalogix launched a newer version of its radiation dose management platform with additional fluoroscopy capabilities. The software solution can automatically calculate the peak skin dose for the patient during a fluoroscopic procedure.
  • In August 2018, Guerbet LLC USA, a subsidiary of the Guerbet Group, partnered with Imalogix to decrease inconsistency and advance the quality, safety, and competence of care around radiation dose management, to enable the network health system and member facilities to monitor patient radiation dose on a per-procedure and cumulative basis.
  • In March 2018, PACSHealth, LLC launched DoseMonitor, a radiation dose management software for tracking radiation dose absorption.

Demand - Drivers and Limitations

Following are the drivers for the global radiation dose management market:

  • Increasing installed bases of radiology equipment and the number of scans lead to a higher risk of radiation exposure, thus creating demand for dose management solutions.
  • The increasing prevalence of cardiovascular diseases and growing occupational hazards in cath labs lead to the growing concern surrounding the effects of radiation exposure.
  • Growing focus on interventional radiology (IR) is expected to increase demand for IR imaging systems and subsequently lead to a higher risk of radiation exposure.
  • Increasing concern related to radiation overexposure is leading to higher adoption of dose management solutions.
  • Growing awareness and initiatives for radiation dose management are expected to push the adoption of dose management software.
  • Advancements in dose optimization and benchmarking in various countries will encourage healthcare institutions to adopt dose management software.

The market is expected to face some limitations as well due to the following challenges:

  • The lack of awareness among the population and the shortage of skilled and trained professionals leading to a steep learning curve hinders the adoption of dose management software.
  • The lack of diagnostic reference levels (DRLs) for radiation dose benchmarking in low-income countries causes healthcare institutions to not pursue the adoption of dose management software with vigor.

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader understand the different types of radiation dose management software available for use in hospitals and diagnostic centers. Moreover, the study provides the reader with a detailed understanding of the different radiation dose products based on the modalities they are compatible with (CT scanners, X-Ray, CR, and DR, mammography system, interventional angiography systems/angio CT, fluoroscopy systems, PET scanners and SPECT, and hybrid imaging), the modes on which they can be deployed (cloud-based, web-based, and on-premises), and the end users who can adopt such software (hospitals, diagnostic centers, and others).

Growth/Marketing Strategy: The global radiation dose management market has seen developments by key players operating in the market, such as partnerships, collaborations and business expansions, and new product launches. Partnerships accounted for the maximum number of key developments, i.e., nearly 70.00% of the total developments in the global radiation dose management market.

Competitive Strategy: Key players in the global radiation dose management market analyzed and profiled in the study involve players that offer radiation dose software. Moreover, a detailed market share analysis of the players operating in the global radiation dose management market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the key players in this market are:

  • Agfa-Gevaert Group
  • Sectra AB
  • Bracco
  • Guerbet
  • Canon Inc.
  • General Electric Company
  • FUJIFILM Holdings Corporation
  • Imalogix
  • Infinitt Healthcare Co. Ltd.
  • Koninklijke Philips N.V.
  • Medic Vision Imaging Solutions Ltd.
  • Medsquare
  • MyXrayDose Ltd.
  • PACSHealth, LLC
  • Qaelum NV
  • Bayer AG
  • SST Group Inc.
  • Siemens Healthineers AG

Companies that are not a part of the previously mentioned pool have been well represented across different sections of the report (wherever applicable).

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

Research Methodology

1. Market Overview

  • 1.1 Overview
    • 1.1.1 Natural Radiation Sources
    • 1.1.2 Biological Effects of Radiation
    • 1.1.3 Usage of Radiation in Medical Devices
    • 1.1.4 Radiation Dose
    • 1.1.5 Effective Radiation Dose
    • 1.1.6 Factors Contributing to Unnecessary Radiation Exposure
    • 1.1.7 Radiation Exposure Trend
  • 1.2 Key Trends
  • 1.3 Opportunity Assessment
  • 1.4 Patent Analysis
  • 1.5 Comparative Analysis
  • 1.6 Market Gap Analysis
  • 1.7 Pricing Analysis
  • 1.8 Change in Competitive Landscape and Product Demand

2. Market Dynamics

  • 2.1 Overview
    • 2.1.1 Impact Analysis
  • 2.2 Market Drivers
  • 2.3 Market Restraints
  • 2.4 Market Opportunities

3. Global Radiation Dose Management Market: Competitive Landscape

  • 3.1 Overview
  • 3.2 Corporate Strategies
    • 3.2.1 Mergers and Acquisitions
    • 3.2.2 Synergistic Activities
    • 3.2.3 Business Expansions and Funding
  • 3.3 Business Strategies
    • 3.3.1 Product Launches and Approvals
    • 3.3.2 Publications
    • 3.3.3 Licenses and Agreements
    • 3.3.4 Other Activities
  • 3.4 Market Share Analysis

4. Global Radiation Dose Management Market (by Modality), Value ($million), 2023-2035

  • 4.1 Overview
  • 4.2 CT Scanners
  • 4.3 X-Ray, CR, and DR
  • 4.4 Mammography Systems
  • 4.5 Interventional Angiography Systems/Angio CT
  • 4.6 Fluoroscopy Systems
  • 4.7 PET Scanners and SPECT
  • 4.8 Hybrid Imaging

5. Global Radiation Dose Management Market (by Product), Value ($million), 2023-2035

  • 5.1 Overview
  • 5.2 Radimetrics Enterprise Platform
    • 5.2.1 Key Features
    • 5.2.2 Radimetrics Enterprise Platform- Global Market
    • 5.2.3 Installed Base
    • 5.2.4 Compatible Modalities
    • 5.2.5 Competitive Benchmarking
  • 5.3 DoseWatch and DoseWatch Explore
    • 5.3.1 Key Features
    • 5.3.2 DoseWatch and DoseWatch Explore- Global Market
    • 5.3.3 Installed Base
    • 5.3.4 Compatible Modalities
    • 5.3.5 Competitive Benchmarking
  • 5.4 teamplay Dose
    • 5.4.1 Key Features
    • 5.4.2 teamplay Dose- Global Market
    • 5.4.3 Installed Base
    • 5.4.4 Compatible Modalities
    • 5.4.5 Competitive Benchmarking
  • 5.5 NEXO [DOSE]
    • 5.5.1 Key Features
    • 5.5.2 NEXO [DOSE]- Global Market
    • 5.5.3 Installed Base
    • 5.5.4 Compatible Modalities
    • 5.5.5 Competitive Benchmarking
  • 5.6 tqm/Dose and DoseMonitor
    • 5.6.1 Key Features
    • 5.6.2 tqm/Dose and DoseMonitor- Global Market
    • 5.6.3 Installed Base
    • 5.6.4 Compatible Modalities
    • 5.6.5 Competitive Benchmarking
  • 5.7 Radiation Dose Monitor
    • 5.7.1 Key Features
    • 5.7.2 Radiation Dose Monitor- Global Market
    • 5.7.3 Installed Base
    • 5.7.4 Compatible Modalities
    • 5.7.5 Competitive Benchmarking
  • 5.8 Imalogix Platform
    • 5.8.1 Key Features
    • 5.8.2 Imalogix Platform- Global Market
    • 5.8.3 Installed Base
    • 5.8.4 Compatible Modalities
    • 5.8.5 Competitive Benchmarking
  • 5.9 Syncro-Dose
    • 5.9.1 Key Features
    • 5.9.2 Syncro-Dose- Global Market
    • 5.9.3 Installed Base
    • 5.9.4 Compatible Modalities
    • 5.9.5 Competitive Benchmarking
  • 5.10 NovaDose
    • 5.10.1 Key Features
    • 5.10.2 NovaDose- Global Market
    • 5.10.3 Installed Base
    • 5.10.4 Compatible Modalities
    • 5.10.5 Competitive Benchmarking
  • 5.11 DoseWise Portal
    • 5.11.1 Key Features
    • 5.11.2 DoseWise Portal- Global Market
    • 5.11.3 Installed Base
    • 5.11.4 Compatible Modalities
    • 5.11.5 Competitive Benchmarking
  • 5.12 SafeCT
    • 5.12.1 Key Features
    • 5.12.2 SafeCT- Global Market
    • 5.12.3 Installed Base
    • 5.12.4 Compatible Modalities
    • 5.12.5 Competitive Benchmarking
  • 5.13 MyXrayDose
    • 5.13.1 Key Features
    • 5.13.2 MyXrayDose- Global Market
    • 5.13.3 Installed Base
    • 5.13.4 Compatible Modalities
    • 5.13.5 Competitive Benchmarking
  • 5.14 DoseM
    • 5.14.1 Key Features
    • 5.14.2 DoseM- Global Market
    • 5.14.3 Installed Base
    • 5.14.4 Compatible Modalities
    • 5.14.5 Competitive Benchmarking
  • 5.15 Dose Tracking System
    • 5.15.1 Key Features
    • 5.15.2 Dose Tracking System- Global Market
    • 5.15.3 Installed Base
    • 5.15.4 Compatible Modalities
    • 5.15.5 Competitive Benchmarking
  • 5.16 DoseTrack
    • 5.16.1 Key Features
    • 5.16.2 DoseTrack- Global Market
    • 5.16.3 Installed Base
    • 5.16.4 Compatible Modalities
    • 5.16.5 Competitive Benchmarking

6. Global Radiation Dose Management Market (by Mode of Deployment), Value ($Million), 2023-2035

  • 6.1 Overview
  • 6.2 Web-Based
  • 6.3 On-Premises
  • 6.4 Cloud Based

7. Global Radiation Dose Management Market (by Application), Value ($Million), 2023-2035

  • 7.1 Overview
  • 7.2 Oncology
  • 7.3 Cardiology
  • 7.4 Orthopaedics
  • 7.5 Other Applications

8. Global Radiation Dose Management Market (by End User), Value ($Million), 2023-2035

  • 8.1 Overview
  • 8.2 Hospitals
  • 8.3 Diagnostic Centers
  • 8.4 Others

9. Global Radiation Dose Management Market (by Region), Value ($Million), 2023-2035

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 France
    • 9.3.3 U.K
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Netherlands
    • 9.3.7 Rest-of-Europe
  • 9.4 Asia-Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia & New Zealand
    • 9.4.5 South Korea
    • 9.4.6 Rest-of-Asia-Pacific (RoAPAC)
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest-of-Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Middle East
    • 9.6.2 Africa

10. Company Profiles

  • 10.1 Agfa-Gevaert Group
    • 10.1.1 Company Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Target Customers/ End Users
    • 10.1.4 Analyst View
  • 10.2 Bracco
    • 10.2.1 Company Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Target Customers/ End Users
    • 10.2.4 Analyst View
  • 10.3 Bayer AG
    • 10.3.1 Company Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Target Customers/ End Users
    • 10.3.4 Analyst View
  • 10.4 Canon Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Target Customers/ End Users
    • 10.4.4 Analyst View
  • 10.5 FUJIFILM Holdings Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Target Customers/ End Users
    • 10.5.4 Analyst View
  • 10.6 Guerbet
    • 10.6.1 Company Overview
    • 10.6.2 Product Portfolio
    • 10.6.3 Target Customers/ End Users
    • 10.6.4 Analyst View
  • 10.7 General Electric Company
    • 10.7.1 Company Overview
    • 10.7.2 Product Portfolio
    • 10.7.3 Target Customers/ End Users
    • 10.7.4 Analyst View
  • 10.8 Imalogix
    • 10.8.1 Company Overview
    • 10.8.2 Product Portfolio
    • 10.8.3 Target Customers/ End Users
    • 10.8.4 Analyst View
  • 10.9 Infinitt Healthcare Co., Ltd.
    • 10.9.1 Company Overview
    • 10.9.2 Product Portfolio
    • 10.9.3 Target Customers/ End Users
    • 10.9.4 Analyst View
  • 10.10 LANDAUER
    • 10.10.1 Company Overview
    • 10.10.2 Product Portfolio
    • 10.10.3 Target Customers/ End Users
    • 10.10.4 Analyst View
  • 10.11 Medsquare
    • 10.11.1 Company Overview
    • 10.11.2 Product Portfolio
    • 10.11.3 Target Customers/ End Users
    • 10.11.4 Analyst View
  • 10.12 Medic Vision Imaging Solutions Ltd.
    • 10.12.1 Company Overview
    • 10.12.2 Product Portfolio
    • 10.12.3 Target Customers/ End Users
    • 10.12.4 Analyst View
  • 10.13 MyXrayDose Ltd.
    • 10.13.1 Company Overview
    • 10.13.2 Product Portfolio
    • 10.13.3 Target Customers/ End Users
    • 10.13.4 Analyst View
  • 10.14 Novarad Corporation
    • 10.14.1 Company Overview
    • 10.14.2 Product Portfolio
    • 10.14.3 Target Customers/ End Users
    • 10.14.4 Analyst View
  • 10.15 PACSHealth, LLC
    • 10.15.1 Company Overview
    • 10.15.2 Product Portfolio
    • 10.15.3 Target Customers/ End Users
    • 10.15.4 Analyst View
  • 10.16 Qaelum NV
    • 10.16.1 Company Overview
    • 10.16.2 Product Portfolio
    • 10.16.3 Target Customers/ End Users
    • 10.16.4 Analyst View
  • 10.17 Sectra AB
    • 10.17.1 Company Overview
    • 10.17.2 Product Portfolio
    • 10.17.3 Target Customers/ End Users
    • 10.17.4 Analyst View
  • 10.18 SST Group Inc.
    • 10.18.1 Company Overview
    • 10.18.2 Product Portfolio
    • 10.18.3 Target Customers/ End Users
    • 10.18.4 Analyst View
  • 10.19 Siemens Healthineers AG
    • 10.19.1 Company Overview
    • 10.19.2 Product Portfolio
    • 10.19.3 Target Customers/ End Users
    • 10.19.4 Analyst View
  • 10.20 Virtual Phantoms Inc.
    • 10.20.1 Company Overview
    • 10.20.2 Product Portfolio
    • 10.20.3 Target Customers/ End Users
    • 10.20.4 Analyst View